[go: up one dir, main page]

ES2159306T3 - Vacuna contra coccidiosis en pollos. - Google Patents

Vacuna contra coccidiosis en pollos.

Info

Publication number
ES2159306T3
ES2159306T3 ES95202485T ES95202485T ES2159306T3 ES 2159306 T3 ES2159306 T3 ES 2159306T3 ES 95202485 T ES95202485 T ES 95202485T ES 95202485 T ES95202485 T ES 95202485T ES 2159306 T3 ES2159306 T3 ES 2159306T3
Authority
ES
Spain
Prior art keywords
against coccidiosis
vaccine against
chickens
protein
coccidiosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95202485T
Other languages
English (en)
Inventor
Fiona Margaret Tomley
Paul Patrick James Dunn
Arnoldus Nicolaas Vermeulen
Janene Marylin Bumstead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2159306T3 publication Critical patent/ES2159306T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNA NUEVA PROTEINA DE EIMERIA CON PROPIEDADES INMUNOGENICAS ASI COMO A SECUENCIAS DE ADN QUE CODIFICAN ESTAS PROTEINAS. ESTA PROTEINA SE PUEDE ADMINISTRAR A AVES DE CORRAL PARA PROTEGERLAS CONTRA LA COCCIDIOSIS. ADEMAS, EL ADN QUE CODIFICA ESTA PROTEINA SE PUEDE UTILIZAR PARA LA PREPARACION DE UNA VACUNA DE VECTOR CONTRA LA COCCIDIOSIS.
ES95202485T 1994-09-16 1995-09-13 Vacuna contra coccidiosis en pollos. Expired - Lifetime ES2159306T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202676 1994-09-16

Publications (1)

Publication Number Publication Date
ES2159306T3 true ES2159306T3 (es) 2001-10-01

Family

ID=8217203

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95202485T Expired - Lifetime ES2159306T3 (es) 1994-09-16 1995-09-13 Vacuna contra coccidiosis en pollos.

Country Status (14)

Country Link
US (2) US5885568A (es)
EP (1) EP0709460B1 (es)
JP (1) JPH08127593A (es)
AT (1) ATE201446T1 (es)
AU (1) AU707356B2 (es)
CA (1) CA2158395A1 (es)
DE (1) DE69521007T2 (es)
DK (1) DK0709460T3 (es)
ES (1) ES2159306T3 (es)
GR (1) GR3036249T3 (es)
HU (1) HU221123B1 (es)
NZ (1) NZ272945A (es)
PT (1) PT709460E (es)
ZA (1) ZA957701B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI348376B (en) 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
WO2004052393A1 (en) * 2002-12-09 2004-06-24 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
WO2005010163A2 (en) * 2003-07-15 2005-02-03 Barros Research Institute Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv)
JP2008500005A (ja) * 2003-07-15 2008-01-10 バロス リサーチ インスティテュート 癌及び感染症の免疫療法のための組成物及び方法
US6924135B2 (en) * 2003-08-29 2005-08-02 Zeon Corporation DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
DE602005021873D1 (de) 2004-03-12 2010-07-29 Univ Georgia Neues impfstoffadjuvans und dessen herstellung und verwendung
US6986264B1 (en) * 2004-07-15 2006-01-17 Carrier Corporation Economized dehumidification system
EP1666489B1 (en) * 2004-12-01 2007-11-21 Zeon Corporation DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof
CN1304056C (zh) * 2005-07-22 2007-03-14 佛山市正典生物技术有限公司 一种球虫病疫苗助悬剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
CA1340838C (en) * 1986-08-14 1999-12-07 Michael Wallach Coccidiosis vacine
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ZA889230B (en) * 1988-02-12 1989-08-30 Us Agriculture Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response and method of producing the same
EP0575317B1 (en) * 1991-03-14 1996-08-14 British Technology Group Usa Inc. Recombinant anticoccidial vaccine
EP0653489B1 (en) * 1993-11-12 2003-02-19 Akzo Nobel N.V. Coccidiosis poultry vaccin

Also Published As

Publication number Publication date
AU707356B2 (en) 1999-07-08
US5885568A (en) 1999-03-23
HU221123B1 (en) 2002-08-28
HUT72405A (en) 1996-04-29
DE69521007T2 (de) 2001-10-25
GR3036249T3 (en) 2001-10-31
DK0709460T3 (da) 2001-08-13
HU9502713D0 (en) 1995-11-28
EP0709460A1 (en) 1996-05-01
CA2158395A1 (en) 1996-03-17
US6001363A (en) 1999-12-14
ZA957701B (en) 1996-04-24
AU3172095A (en) 1996-03-28
PT709460E (pt) 2001-10-30
EP0709460B1 (en) 2001-05-23
NZ272945A (en) 1997-12-19
ATE201446T1 (de) 2001-06-15
JPH08127593A (ja) 1996-05-21
DE69521007D1 (de) 2001-06-28

Similar Documents

Publication Publication Date Title
ES2117029T3 (es) Vacuna contra la coccidiosis aviar.
AR044234A2 (es) Uso de una composicion que comprende oocistos de eimeria vivos
DE69939747D1 (de) Verfahren von dna-impfung
EA199800946A1 (ru) Концентрированный препарат антител
ES2192559T3 (es) Vacuna para la proteccion de aves de corral contra la coccidiosis.
ES2159306T3 (es) Vacuna contra coccidiosis en pollos.
AR044235A2 (es) Uso de una composicion que comprende merozoitos de eimeria vivos
MX2020009150A (es) Anfifilos de cpg y usos de los mismos.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ES2050435T3 (es) Una preparacion medicinal o vacuna y composicion inmunogenica peptida, un metodo de inmunizacion de un mamifero contra lhrh, y un metodo para mejorar la calidad carnica del ganado porcuno.
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
ES2061521T3 (es) Proteinas con actividad glutation-s-transferasa, secuencias de adn, anticuerpos, poxvirus y medicamentos para la prevencion de la equistosomiasis.
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
GT199900213A (es) Formulaciones antiparàsitos.-
ES2192608T3 (es) Uso de derivados de alilamina tales como terbinafina, en la fabricacion de un medicamento para el tratamiento de la infeccion por helicobacter pylori de enfermedades asociadas.
ES2059711T3 (es) Metodo para la preparacion de una secuencia de acido nucleico codificante de un polipeptido de eimeria tenella.
PT907737E (pt) Muteina da il-6
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
ECSP961785A (es) Vacunacion in ovo contra la coccidiosis
UY26762A1 (es) Inmunización del ganado lacteo con proteína mig.
AR006382A1 (es) Procedimiento para el tratamiento del envejecimiento cutaneo y de lesiones atroficas mediante la administracion de una preparacion conteniendoacido hialuronico y/o hialuronatos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 709460

Country of ref document: ES